Michael Bengtson, MD

College Of Medicine Psychiatry And Behavioral Neurosciences

Academic Email: mbengtso@health.usf.edu

Academic Phone: (813) 974-5926

Education

  • MD, University Of Alabama - School Of Medicine, 1989

Interdisciplinary and Emerging Signature Programs

  • Neuroscience

Recent Publications

  • Ried, LD.Brumback, B.Bengtson, MA.Garman, PM.Hsu, C.McConkey, JR. Glucose dysregulation among veterans living with schizophrenia-related disorders after switching second-generation antipsychotics. Journal of the American Pharmacists Association : JAPhA. 49(2) : 223-31http://www.ncbi.nlm.nih.gov/pubmed/19289350
  • Hsu, C.Ried, LD.Bengtson, MA.Garman, PM.McConkey, JR.Rahnavard, F. Metabolic monitoring in veterans with schizophrenia-related disorders and treated with second-generation antipsychotics: findings from a Veterans Affairs-based population. Journal of the American Pharmacists Association : JAPhA. 48(3) : 393-400http://www.ncbi.nlm.nih.gov/pubmed/18595825
  • Storch, EA.Murphy, TK.Goodman, WK.Geffken, GR.Lewin, AB.Henin, A.Micco, JA.Sprich, S.Wilhelm, S.Bengtson, M.Geller, DA. A preliminary study of D-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biological psychiatry. 68(11) : 1073-6, 2010. http://www.ncbi.nlm.nih.gov/pubmed/20817153
  • Murphy, TK.Mutch, PJ.Reid, JM.Edge, PJ.Storch, EA.Bengtson, M.Yang, M. Open label aripiprazole in the treatment of youth with tic disorders. Journal of child and adolescent psychopharmacology. 19(4) : 441-7, 2009. http://www.ncbi.nlm.nih.gov/pubmed/19702496
  • Leonard, CM.Kuldau, JM.Maron, L.Ricciuti, N.Mahoney, B.Bengtson, M.DeBose, C. Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia. Neuropsychology. 22(2) : 147-58, 2008. http://www.ncbi.nlm.nih.gov/pubmed/18331156
  • Storch, EA.Merlo, LJ.Bengtson, M.Murphy, TK.Lewis, MH.Yang, MC.Jacob, ML.Larson, M.Hirsh, A.Fernandez, M.Geffken, GR.Goodman, WK. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. International clinical psychopharmacology. 22(4) : 230-7, 2007. http://www.ncbi.nlm.nih.gov/pubmed/17519647